{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-115255","form_type":"8-K","ticker":"ASTH","cik":"0001083446","company_name":"Astrana Health, Inc.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.158974+00:00","generated_at":"2026-06-08T13:19:51.173818+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Apollo Medical enters $300M term loan facility, $180M funded at close","bullets":["New Term Loan of up to $300M: $180M funded on Nov 3, 2023; $120M delayed draw available for 6 months.","Matures Nov 3, 2028; amortizes 5%/yr for first 2 years, 7.5% for years 3-4, 10% for year 5.","Interest at SOFR + 1.50%-2.75% or base rate + 0.50%-1.75%, based on leverage ratio.","Proceeds used to refinance outstanding revolving loans and for permitted acquisitions and share repurchases.","Revolving line of credit unchanged at $400M, maturing June 16, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-115255","json":"https://secwatch.observer/filing/0001104659-23-115255.json","markdown":"https://secwatch.observer/filing/0001104659-23-115255.md","text":"https://secwatch.observer/filing/0001104659-23-115255.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923115255/0001104659-23-115255-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923115255/tm2329882d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T13:19:51.173818+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"437c79e2f6949cf8d18ce8793e69c35080e91247","claim":"Astrana Health, Inc. amended credit facility of $400.0 million with Truist Bank at subject to a spread based on the Company's leverage ratio maturing June 16, 2026.","evidence_excerpt":"The Credit Agreement Amendment does not change the amount of the Revolving Line of Credit (which remains at $400.0 million), the maturity date of the Revolving Line of Credit (which remains June 16, 2026), or the rate of interest paid on the Revolving Line of Credit (which remains subject to a spread based on the Company's leverage ratio).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923115255/0001104659-23-115255-index.htm","confidence":0.4,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Principal","value":"$400.0 million"},{"label":"Counterparty","value":"Truist Bank"},{"label":"Rate","value":"subject to a spread based on the Company's leverage ratio"},{"label":"Maturity","value":"June 16, 2026"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"9ca6629e0eaf7b25a7ef7d99c948061eb53e55ea","claim":"Astrana Health, Inc. incurred term loan of up to $300.0 million, with $180.0 million funded at the closing with Truist Bank at Term SOFR Reference Rate plus a spread from 1.50% to 2.75% maturing November 3, 2028.","evidence_excerpt":"The Credit Agreement Amendment provides a new term loan to the Company in an aggregate amount of up to $300.0 million, with $180.0 million funded at the closing of the Credit Agreement Amendment, and $120.0 million available to be drawn by the Company as delayed draw loans during the six months subsequent to the closing of the Credit Agreement Amendment (collectively, the \"New Term Loan\").","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923115255/0001104659-23-115255-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"up to $300.0 million, with $180.0 million funded at the closing"},{"label":"Counterparty","value":"Truist Bank"},{"label":"Rate","value":"Term SOFR Reference Rate plus a spread from 1.50% to 2.75%"},{"label":"Maturity","value":"November 3, 2028"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"27fbd8a9a2b36357185ec7edb1b3cc68d7a57901","claim":"Astrana Health, Inc. amended Third Amendment to Amended and Restated Credit Agreement and Incremental Agreement with Truist Bank, as administrative agent, and the banks and other financial institutions party thereto valued at $300.0 million, with $180.0 million funded at the closing (effective 2023-11-03).","evidence_excerpt":"On November 3, 2023, Apollo Medical Holdings, Inc. (the “Company”) entered into a Third Amendment to Amended and Restated Credit Agreement and Incremental Agreement (the “Credit Agreement Amendment”) with the banks and other financial institutions party thereto and Truist Bank, as administrative agent (the “Administrative Agent”), which amends the Amended and Restated Credit Agreement, dated as of June 16, 2021, entered into among the Company, the lenders party thereto and the Administrative Agent (as amended, the “Credit Agreement”). The Credit Agreement Amendment provides a new term loan to the Company in an aggregate amount of up to $300.0 million, with $180.0 million funded at the closing of the Credit Agreement Amendment","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923115255/0001104659-23-115255-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Truist Bank, as administrative agent, and the banks and other financial institutions party thereto"},{"label":"Value","value":"$300.0 million, with $180.0 million funded at the closing"},{"label":"Effective","value":"2023-11-03"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}